Bionaut Labs
PrivateLast Round
Series B
Extension
Feb 6, 2024
Est. Valuation
$122.8M
Total Funding Raised
$96M
Company Overview
Bionaut Labs is a biotechnology company that develops micro-robotic systems capable of accessing anatomical locations in the body to deliver precision treatments for central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionaut Labs Comparables
Compare Bionaut Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Robeauté | 78% | |
| Nanobots Therapeutics | 75% | |
| DNA Nanobots | 69% |
Bionaut Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 6, 2024 | ||||
| Series B | Nov 28, 2022 | ||||
| Series A | Mar 3, 2021 | ||||
| Series A | Jun 1, 2019 |
Bionaut Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GISEV | Series B |
| Sixty Degree Capital | Series B |
| Dolby Family Ventures | Series B |
| Deep Insight | Series B |
| Khosla Ventures | Series B Extension, Series A, Series B |
| Gaingels | Series B |
| Public Safety Personnel Retirement System | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 6, 2024
$7M round with participation from Khosla Ventures and Upfront Ventures.
Bionaut Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bionaut Labs's valuation, stock price, and market status.
Is Bionaut Labs a public or private company?
Bionaut Labs is a private company.
What is the current stock price of Bionaut Labs?
Bionaut Labs is a private company, so its shares have no public market price. Caplight tracks Bionaut Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bionaut Labs worth (valuation)?
Bionaut Labs's valuation is estimated at $122.8M based on funding round data.
Can I buy Bionaut Labs stock?
Bionaut Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bionaut Labs's last funding round?
Bionaut Labs's most recent funding round was Series B Extension on February 6, 2024.
Who are the main investors in Bionaut Labs?
Key investors in Bionaut Labs include Khosla Ventures.
Will Bionaut Labs IPO soon?
No public IPO plans have been announced for Bionaut Labs.
How can I track Bionaut Labs secondary market activity?
Caplight tracks bids, offers, and trades in Bionaut Labs's shares on secondary markets.